Your search history is turned on.
Date: May 6, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Doreen McMorran, Chief Financial Officer of OVATION SCIENCE INC., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated...
Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Terry Howlett, Chief Executive Officer of OVATION SCIENCE INC., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by...
OVATION SCIENCE INC. Management Discussion & Analysis For the years ended December 31, 2023 and 2022 CSE: OVAT | OTCQB: OVATF 1 MANAGEMENTS DISCUSSION AND ANALYSIS The following Management Discussion and Analysis (MD&A) has been prepa...
OVATION SCIENCE INC. Consolidated Financial Statements For the years ended December 31, 2023 and 2022 Expressed in Canadian dollars Independent Auditor's Report To the Shareholders of Ovation Science Inc. Opinion We have audited the consolidated financial statements of Ovation Science Inc. (the Co...
Date: May 6, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, MCMORRAN, Doreen, an officer of the reporting issuer noted below have examined this Form 13- 502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasona...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
Date: April 30, 2024 Jurisdictions: Alberta, British Columbia, Ontario
1 Ovation Science Topicals Launch with Planet 13 in Nevada Vancouver, BC, Las Vegas, NV April 30, 2024 (CSE: OVAT | OTCQB: OVATF) Ovation Science Inc. (Ovation or the Company), with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology...
Date: April 8, 2024 Jurisdictions: British Columbia
Create report of exempt distribution (Form 45-106F1) Form 45-106F1 Report of Exempt Distribution ITEM 1 - REPORT TYPE New report Amended report If amended, provide filing date of report that is being amended. (YYYY-MM-DD) ITEM 2 - PARTY CERTIFYING THE REPORT Indicate the party certifying the report (select only one). For guidance regarding whether an ...
Date: March 20, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Skinvisible conducts further studies on Hand Sanitizer effective at killing bird flu H5N1 virus OVATION SCIENCE INC. ANNOUNCES PRIVATE PLACEMENT Vancouver, BC March 20, 2024 (CSE: OVAT) Ovation Science Inc. (Ovation or the Company) announces that it intends to close a private place...
Date: November 27, 2023 Jurisdictions: Alberta, British Columbia, Ontario
Form 52-109FV2 Certification of interim filings - venture issuer basic certificate I, Doreen McMorran, Chief Financial Officer of OVATION SCIENCE INC., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of OVATION SCIENCE INC. (the Issuer) for the interim period ended September 30...